Nociceptin(1-7)(Orphanin FQ(1-7))
Modify Date: 2025-08-21 13:20:00
Nociceptin(1-7)(Orphanin FQ(1-7)) structure
|
Common Name | Nociceptin(1-7)(Orphanin FQ(1-7)) | ||
|---|---|---|---|---|
| CAS Number | 178249-42-8 | Molecular Weight | 655.69900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C31H41N7O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Nociceptin(1-7)(Orphanin FQ(1-7))Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin (HY-P0183). Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo[1]. |
| Name | (2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin (HY-P0183). Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Nociceptin (1-7) (intrathecal injection; 150–1200 nmol; single dose) has no significant effect in the nociceptive thermal threshold (hyperalgesia). However, when nociceptin (1–7) is injected simultaneously with nociceptin (3.0 fmol), nociceptin-induced hyperalgesia is significantly reduced[1]. Animal Model: Mice[1] Dosage: 150–1200 nmol Administration: Intrathecal injection; single dose Result: Co-treatment with nociceptin could reduce hyperalgesia. |
| References |
| Molecular Formula | C31H41N7O9 |
|---|---|
| Molecular Weight | 655.69900 |
| Exact Mass | 655.29700 |
| PSA | 279.09000 |
| LogP | 2.82950 |
| InChIKey | KVTLKXLQUDUFSD-FLSSTNBBSA-N |
| SMILES | CC(NC(=O)CNC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc1ccccc1)C(C)O)C(=O)O |
| TCS JNK 6o |
| L-Alanine,L-phenylalanylglycylglycyl-L-phenylalanyl-L-threonylglycyl |